From: Gram-stain-based antimicrobial selection reduces cost and overuse compared with Japanese guidelines
N = 208 | |
---|---|
Age (median, interquartile range) | 80 (67–87) |
Male | 71 (34.1 %) |
Performance status | |
0–2 | 126 (60.5 %) |
3 (in bed or chair more than 50 %) | 41 (19.7 %) |
4 (bedridden) | 41 (19.7 %) |
Living place before admission | |
Home | 151 (72.6 %) |
Nursing and healthcare facility | 54 (25.9 %) |
Hospital | 3 (1.4 %) |
Infection site | |
Pulmonary system | Subtotal = 45 |
Community-acquired pneumonia | 7 (3.3 %) |
Aspiration pneumonia | 38 (18.2 %) |
Urinary tract | Subtotal = 105 |
Pyelonephritis | 20 (9.6 %) |
Complicated pyelonephritis | 67 (32.2 %) |
Urosepsis | 8 (3.8 %) |
Prostatitis | 5 (2.4 %) |
Catheter related pyelonephritis | 5 (2.4 %) |
Skin & soft tissue | Subtotal = 58 |
Cellulitis | 34 (16.3 %) |
Severe cellulitis | 18 (8.6 %) |
MRSA suspected cellulitis | 6 (2.8 %) |
Previous antibiotic exposure within 48 h | 29 (13.9 %) |
Gram stain performed at ER | 149 (71.6 %) |
Blood culture positivity | 34 (16.3 %) |
Death | 1 (0.4 %) |